Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bibob
    wrote on sidst redigeret af
    #828

    Og Novartis har Q1 27 apr. Kunne måske også komme en lille overraskelse fra Kesimpta. ! https://www.novartis.com/investors/event-calendar

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Plimsoller
      wrote on sidst redigeret af
      #829

      Vi må håbe at guidance er lavt sat, og at en opjustering vil vinde noget af det tabte tilbage.

      1 Reply Last reply
      0
      • D Offline
        D Offline
        deleted-user
        wrote on sidst redigeret af
        #830

        Mon der er nogle investorer der lugter gode salgstal i morgen?

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #831

          morgan stanley der har sat deres robot til at købe nu hvor TA indikere medvind

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #832

            Link Preview Image
            Roche publicerer nye sklerosedata for at holde Novartis fra døren

            Med den nyligt godkendte sklerosemedicin Kesimpta - oprindeligt udviklet af Genmab - er Novartis i fuld gang med at lange ud efter Roches dominerende lægemiddel på markedet, og nu prøver Roche at slå igen.

            favicon

            (medwatch.dk)

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #833

              Langers Skarpe: Deltag i festen, men undgå tømmermænd og forlad den i tide

              Just a moment...

              favicon

              (www.proinvestor.com)

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #834

                Health Canada-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis / Dara https://www.newswire.ca/news-releases/darzalex-r-sc-becomes-the-first-and-only-health-canada-approved-treatment-for-patients-with-newly-diagnosed-light-chain-al-amyloidosis-a-rare-disease-849615211.html

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #835

                  CEO Jan van de Winkel rykker op på førstepladsen i Økonomisk Ugebrevs årlige CEO Performance-ranking. https://ugebrev.dk/ledelse/genmab-vinder-ceo-performance-redningsplan-blev-succes/

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #836

                    waiting for this, New trial - A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab https://clinicaltrials.gov/ct2/show/NCT04847596

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #837

                      yes, pretty important these days

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #838

                        These results obtained after 12 months of maintenance therapy reveal the potential of D-VRd and D-R maintenance as a new treatment for patients with NDMM who are eligible for transplant.
                        https://multiplemyelomahub.com/medical-information/daratumumab-plus-vrd-vs-vrd-in-newly-diagnosed-mm-griffin-trial-updated-analysis

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #839

                          i expect this to be an area we will hear a lot more about , Dara maintanenance, we should be getting more and more data there. Also hope we will get some smoldering data soon. Next areas of expansion.

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #840

                            Just a moment...

                            favicon

                            (www.firstwordpharma.com)

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #841

                              DARZALEX SC Becomes the First and Only Health Canada-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis, A Rare Disease

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                peter12
                                wrote on sidst redigeret af
                                #842

                                Old news 😉 (15:12)

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #843

                                  God morgen. 🙂

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #844

                                    Asien: Frygt for nye nedlukninger presser japanske selskaber https://www.proinvestor.com/investornyt/674191/asien-frygt-for-nye-nedlukninger-presser-japanske-selskaber

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #845

                                      Genmab/DNB: Kursmål løftet 9 pct. https://www.proinvestor.com/investornyt/674193/genmab-dnb-kursmal-loftet-9-pct-gent

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #846

                                        Tirsdagens danske avisuddrag med Danske Bank, Lego og Hummel https://www.proinvestor.com/investornyt/674194/tirsdagens-danske-avisuddrag-med-danske-bank-lego-og-hummel

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Plimsoller
                                          wrote on sidst redigeret af
                                          #847

                                          God morgen 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger